Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis

The role played by protein turnover in metabolic reprogramming is unknown. Herein, using a SILAC approach, we have studied the changes in the half-life of 266 proteins of energy metabolism and of translation during the metabolic switch induced by the prolyl hydroxylases inhibitor dimethyloxalylglyci...

Full description

Bibliographic Details
Authors: García Aguilar, Ana; Martinez Reyes, Inmaculada; Cuezva, José Manuel
Format: Article
Publication date:2019
Country:España
Institution:Universidad Complutense de Madrid (UCM)
Repository:Docta Complutense
Language:English
OAI Identifier:oai:docta.ucm.es:20.500.14352/115682
Online Access:https://hdl.handle.net/20.500.14352/115682
Access Level:Open access
Keyword:Biología celular (Farmacia)
Biología molecular (Biología)
Bioquímica (Farmacia)
2415 Biología Molecular
2407 Biología Celular
_version_ 1878734360545329153
author García Aguilar, Ana
author2 Martinez Reyes, Inmaculada
Cuezva, José Manuel
author2_role author
author
author_browse Cuezva, José Manuel
García Aguilar, Ana
Martinez Reyes, Inmaculada
author_facet García Aguilar, Ana
Martinez Reyes, Inmaculada
Cuezva, José Manuel
author_role author
collection Docta Complutense
description The role played by protein turnover in metabolic reprogramming is unknown. Herein, using a SILAC approach, we have studied the changes in the half-life of 266 proteins of energy metabolism and of translation during the metabolic switch induced by the prolyl hydroxylases inhibitor dimethyloxalylglycine (DMOG). DMOG induces HIF-1α expression and triggers the activation of glycolysis and the concurrent inhibition of mitochondrial respiration in colon cancer cells. Changes in the activity of energy provision pathways correlated with increased turnover rates of glycolytic enzymes and the stabilization of mitochondrial proteins. Moreover, reprogramming also stabilized the proteins of translation. The partial DMOG-mediated arrest of the synthesis of mitochondrial and translation proteins results from the inhibition of the mTORC1/p70SK/S6 signaling pathway. In contrast, DMOG stimulated the synthesis of glycolytic enzymes, emphasizing the opposite and differential regulation of the two pathways of energy provision. Addition of MitoQ, a mitochondrial reactive oxygen species (mtROS) scavenger, stabilized the turnover of cellular proteins similarly as when protein degradation is inhibited with leupeptin, a serine-protease inhibitor. Overall, the results show that the higher the activity of a pathway the lower is the half-life of the proteins involved and suggest a role for mtROS in cellular proteostasis. Data are available via ProteomeXchange with identifier PXD013482.
eu_rights_str_mv openAccess
format article
id ES_6880b8a2a4dfe322ad817b3c2ae45310
institution Universidad Complutense de Madrid (UCM)
instname_str Universidad Complutense de Madrid (UCM)
language eng
network_acronym_str ES
network_name_str España
oai_identifier_str oai:docta.ucm.es:20.500.14352/115682
publishDate 2019
publishDateSort 2019
publisher American Chemical Society
publisherStr American Chemical Society
reponame_str Docta Complutense
spelling Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis García Aguilar, Ana Martinez Reyes, Inmaculada Cuezva, José Manuel Biología celular (Farmacia) Biología molecular (Biología) Bioquímica (Farmacia) 2415 Biología Molecular 2407 Biología Celular The role played by protein turnover in metabolic reprogramming is unknown. Herein, using a SILAC approach, we have studied the changes in the half-life of 266 proteins of energy metabolism and of translation during the metabolic switch induced by the prolyl hydroxylases inhibitor dimethyloxalylglycine (DMOG). DMOG induces HIF-1α expression and triggers the activation of glycolysis and the concurrent inhibition of mitochondrial respiration in colon cancer cells. Changes in the activity of energy provision pathways correlated with increased turnover rates of glycolytic enzymes and the stabilization of mitochondrial proteins. Moreover, reprogramming also stabilized the proteins of translation. The partial DMOG-mediated arrest of the synthesis of mitochondrial and translation proteins results from the inhibition of the mTORC1/p70SK/S6 signaling pathway. In contrast, DMOG stimulated the synthesis of glycolytic enzymes, emphasizing the opposite and differential regulation of the two pathways of energy provision. Addition of MitoQ, a mitochondrial reactive oxygen species (mtROS) scavenger, stabilized the turnover of cellular proteins similarly as when protein degradation is inhibited with leupeptin, a serine-protease inhibitor. Overall, the results show that the higher the activity of a pathway the lower is the half-life of the proteins involved and suggest a role for mtROS in cellular proteostasis. Data are available via ProteomeXchange with identifier PXD013482. American Chemical Society https://hdl.handle.net/20.500.14352/115682
spellingShingle Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
García Aguilar, Ana
Biología celular (Farmacia)
Biología molecular (Biología)
Bioquímica (Farmacia)
2415 Biología Molecular
2407 Biología Celular
title Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
title_full Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
title_fullStr Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
title_full_unstemmed Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
title_short Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
title_sort Changes in the Turnover of the Cellular Proteome during Metabolic Reprogramming: A Role for mtROS in Proteostasis
topic Biología celular (Farmacia)
Biología molecular (Biología)
Bioquímica (Farmacia)
2415 Biología Molecular
2407 Biología Celular
topic_facet Biología celular (Farmacia)
Biología molecular (Biología)
Bioquímica (Farmacia)
2415 Biología Molecular
2407 Biología Celular
url https://hdl.handle.net/20.500.14352/115682